Anti-herpes simplex virus target of an acidic polysaccharide, nostoflan, from the edible blue-green alga Nostoc flagelliforme

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 8, 2007, Pages 1573-1575

  Kanekiyo, Kenji ^a   Hayashi, Kyoko ^a   Takenaka, Hiroyuki ^b   Lee, Jung Bum ^a   Hayashi, Toshimitsu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b MAC Gifu Research Institute   (Japan)

Author keywords

Antiviral target; Herpes simplex virus; Nostoc flagelliforme; Viral binding process

Indexed keywords

ANTIVIRUS AGENT; NOSTOFLAN; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BLUE GREEN ALGA; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; HERPES SIMPLEX VIRUS 1; HOST CELL; NONHUMAN; NOSTOC FLAGELLIFORME; VERO CELL; VIRUS INACTIVATION; VIRUS INHIBITION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ADSORPTION; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; HERPESVIRUS 1, HUMAN; NOSTOC; POLYSACCHARIDES; SIMPLEXVIRUS; VERO CELLS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 34548035444     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1573     Document Type: Article

References (26)

1. Crumpacker C. S., Schnipper L. E., Zaia J. A., Levin M. J., Antimicrob. Agents Chemother., 15, 642-645 (1979).
2. Burns W. H., Santos G. W., Saral R., Laskin O. L., Lietman P. S., McLaren C., Barry D. W., Lancet, 319, 421-423 (1982).
3. Erlich S. K., Mills J., Chatis P., Mertz G. J., Busch D. F., Follansbee S. E., Grant R. M., Crumpacker C. S., New Engl. J. Med., 320, 293-296 (1988).
4. Chatis P. A., Crumpacker C. S., Virology, 180, 793-797 (1991).
5. Posavad C. M., Koelle D. M., Shaughnessy M. F., Corey L., Proc. Natl. Acad. Sci. U.S.A., 94, 10289-10294 (1997).
6. Kanekiyo K., Lee J.-B., Hayashi K., Takenaka H., Hayakawa Y., Endo S., Hayashi T., J. Nat. Prod., 68, 1037-1041 (2005).
7. Hayashi K., Hayashi T., Ujita K., Takaishi Y., J. Antimicrob. Chemother., 37, 759-768 (1996).
8. Andries K., Dewindt B., Snoecks J., Willebrords R., Van Eemeren K., Stokbroekx R., Janssen P. A. J., Antimicrob. Agents Chemother., 36, 100-107 (1992).
9. Huang A. S., Wagner R. R., Proc. Soc. Exp. Biol. Med., 116, 863-869 (1964).
10. Highlander S. L., Sutherland S. L., Gage P. J., Johnson D. C., Levine M., Glorioso J. C., J. Virol., 61, 3356-3364 (1987).
11. Sambrook J., Fritsch E. F., Maniatis T., "Molecular Cloning: a Laboratory Manual," Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1989.
12. Baba M., Pauwels R., Balzarini J., Arnout J., Desmyter J., De Clercq E., Proc. Natl. Acad. Sci. U.S.A., 85, 6132-6136 (1988).
13. Mitsuya H., Looney D. J., Kuno S., Ueno R., Wong-Staal F., Broder S., Science, 240, 646-649 (1988).
14. Huheihel M., Ishanu V., Tal J., Arad S. M., J. Biochem. Biophys. Methods, 50, 189-200 (2002).
15. Lee J.-B., Hayashi K., Hashimoto M., Nakano T., Hayashi T., Chem. Pharm. Bull., 52, 1091-1094 (2004).
16. Hayashi K., Hayashi T., Kojima I., AIDS Res. Hum. Retroviruses, 12, 1463-1471 (1996).
17. Lee J.-B., Hayashi T., Hayashi K., Sankawa U., J. Nat. Prod., 63, 136-138 (2000).
18. Hoshino T., Hayashi T., Hayashi K., Hamada J., Lee J.-B., Sankawa U., Biol. Pharm. Bull., 21, 730-734 (1998).
19. Preeprame S., Hayashi K., Lee J.-B., Sankawa U., Hayashi T., Chem. Pharm. Bull., 49, 484-485 (2001).
20. Lee J.-B., Hayashi K., Hirata M., Kuroda E., Suzuki E., Kubo Y., Hayashi T., Biol. Pharm. Bull., 29, 2135-2139 (2006).
21. Ligas M. W., Johnson D. C., J. Virol., 62, 1486-1494 (1988).
22. Miller W. H., Miller R. L., J. Biol. Chem., 255, 7204-7207 (1980).
23. Itoh H., Noda H., Amano H., Ito H., Anticancer Res., 15, 1937-1948 (1995).
24. Okai Y., Higashi-Okai K., Ishizaka S., Ohtani K., Matsui-Yuasa I., Yamashita U., J. Sci. Food Agric., 76, 56-62 (1998).
25. Shan B. E., Yoshida Y., Kuroda E., Yamashita U., Int. J. Immunopharmacol., 21, 59-70 (1999).
26. Liu J. N., Yoshida Y., Wang M. Q., Okai Y., Yamashita U., Int. J. Immunopharmacol., 19, 135-142 (1997).